Filing Flows › Comparisons › SNY vs ABT
Sanofi vs Abbott Laboratories: SNY and ABT compared
Sanofi is the larger company: $11.6B of revenue in its latest quarter (Q2 2026) against $13.0B for Abbott Laboratories (Q3 2026). Sanofi is growing faster (+16% against +14% a year earlier). Abbott Laboratories is more profitable, with an operating margin of 10.4% against 9.0%.
Where the money goes: SNY and ABT
Sanofi (SNY) · Q2 2026
Sanofi, Q2 2026: revenue $11.6B (+16% year over year), operating margin 9.0%, net earnings $377M. The chart follows the revenue to costs, profit and cash.
Abbott Laboratories (ABT) · Q3 2026
Abbott Laboratories, Q3 2026: revenue $13.0B (+14% year over year), operating margin 10.4%, net earnings $920M, operating cash flow $1.7B. The chart follows the revenue to costs, profit and cash.
| Sanofi (SNY) | Abbott Laboratories (ABT) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $11.6B | $13.0B |
| Revenue growth, Y/Y | +16% | +14% |
| Operating margin | 9.0% | 10.4% |
| Net earnings | $377M | $920M |
| Net margin | 3.3% | 7.1% |
| Operating cash flow | — | $1.7B |
| Free cash flow | — | $1.2B |
| Market value | — | $197.4B |
| P/E | — | 42.4× |
| Analysts’ mean target | — | $118.52 |
Questions
Which is bigger, Sanofi or Abbott Laboratories?
Sanofi is the larger company: $11.6B of revenue in its latest quarter (Q2 2026) against $13.0B for Abbott Laboratories (Q3 2026).
Is Sanofi or Abbott Laboratories growing faster?
Sanofi is growing faster (+16% against +14% a year earlier).
Which is more profitable, Sanofi or Abbott Laboratories?
Abbott Laboratories is more profitable, with an operating margin of 10.4% against 9.0%.
More: Sanofi earnings · how Sanofi makes money · Abbott Laboratories earnings · how Abbott Laboratories makes money
From the companies' latest 10-Q, 10-K or earnings release (6-K filed Jul 30, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.